Back
Avalo Therapeutics Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
7
AVTX
Avalo Therapeutics
Last Price:
$5.75
Seasonality Move:
28.47%
7 Day Trial
ALL ACCESS PASS
$
7

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVTX is experiencing slight selling pressure.
Avalo Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.49 | Sell |
20-day SMA: | 7.68 | Sell |
50-day SMA: | 7.59 | Sell |
200-day SMA: | 9.68 | Sell |
8-day EMA: | 7.09 | Sell |
20-day EMA: | 7.46 | Sell |
50-day EMA: | 7.73 | Sell |
200-day EMA: | 21.96 | Sell |
Avalo Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.2 | Sell |
Relative Strength Index (14 RSI): | 34.74 | Sell |
Chaikin Money Flow: | -25624 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.89 - 8.23) | Sell |
Bollinger Bands (100): | (6.8 - 10.34) | Sell |
Avalo Therapeutics Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Avalo Therapeutics Stock
Is Avalo Therapeutics Stock a Buy?
-
Avalo Therapeutics share price is 5.80 while AVTX 8-day simple moving average is 7.49, which is a Sell signal.
-
The stock price of AVTX is 5.80 while Avalo Therapeutics 20-day SMA is 7.68, which makes it a Sell.
-
Avalo Therapeutics 50-day simple moving average is 7.59 while AVTX share price is 5.80, making it a Sell technically.
-
AVTX stock price is 5.80 and Avalo Therapeutics 200-day simple moving average is 9.68, creating a Sell signal.
AVTX Technical Analysis vs Fundamental Analysis
Sell
7
Avalo Therapeutics (AVTX)
is a Sell
Is Avalo Therapeutics a Buy or a Sell?
-
Avalo Therapeutics stock is rated a SellThe current Avalo Therapeutics [AVTX] share price is $5.80. The Score for AVTX is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
Avalo Therapeutics Stock Info
Market Cap:
61.9M
Price in USD:
5.80
Share Volume:
51.2K
Avalo Therapeutics 52-Week Range
52-Week High:
18.79
52-Week Low:
5.56
Sell
7
Avalo Therapeutics (AVTX)
is a Sell
Avalo Therapeutics Share Price Forecast
-
What is the Avalo Therapeutics stock price today?The Avalo Therapeutics stock price is 5.80 USD today.
-
Will AVTX stock go up or go down?Avalo Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Avalo Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avalo Therapeutics is overvalued.
Is Avalo Therapeutics Stock a Buy?
-
Avalo Therapeutics share price is 5.80 while AVTX 8-day exponential moving average is 7.09, which is a Sell signal.
-
The stock price of AVTX is 5.80 while Avalo Therapeutics 20-day EMA is 7.46, which makes it a Sell.
-
Avalo Therapeutics 50-day exponential moving average is 7.73 while AVTX share price is 5.80, making it a Sell technically.
-
AVTX stock price is 5.80 and Avalo Therapeutics 200-day simple moving average is 21.96, creating a Sell signal.
Fundamental Analysis of Avalo Therapeutics
Is Avalo Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $3.33 per share, a decrease next quarter of $0.46 per share, a decrease this year of $18.12 per share, and an increase next year of $1.00 per share.
Technical Analysis of Avalo Therapeutics
Should I short Avalo Therapeutics stock?
-
AVTX Moving Average Covergence Divergence (MACD) indicator is -0.2, suggesting Avalo Therapeutics is a Sell
-
Avalo Therapeutics Relative Strength Index (RSI) is 34.74, which suggest Avalo Therapeutics is oversold
-
The Bollinger Bands (25) for Avalo Therapeutics is (6.89 - 8.23), which suggest Avalo Therapeutics is a Sell
-
The Bollinger Bands (100) for Avalo Therapeutics is (6.8 - 10.34), which suggest Avalo Therapeutics is a Sell
* Avalo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.